Sandoz Group AG (0SAN.L)

CHF 36.12

(0.94%)

Operating Expenses Summary of Sandoz Group AG

  • Sandoz Group AG's latest annual operating expenses in 2023 was 3.58 Billion USD , up 21.38% from previous year.
  • Sandoz Group AG's latest quarterly operating expenses in 2024 Q2 was 1.02 Billion USD , down 0.0% from previous quarter.
  • Sandoz Group AG reported a annual operating expenses of 2.95 Billion USD in annual operating expenses 2022, up 0.37% from previous year.
  • Sandoz Group AG reported a annual operating expenses of 2.94 Billion USD in annual operating expenses 2021, down -9.76% from previous year.
  • Sandoz Group AG reported a quarterly operating expenses of 1.02 Billion USD for 2024 Q2, down 0.0% from previous quarter.
  • Sandoz Group AG reported a quarterly operating expenses of 1.15 Billion USD for 2023 Q3, up 32.15% from previous quarter.

Annual Operating Expenses Chart of Sandoz Group AG (2023 - 2020)

Historical Annual Operating Expenses of Sandoz Group AG (2023 - 2020)

Year Operating Expenses Operating Expenses Growth
2023 3.58 Billion USD 21.38%
2022 2.95 Billion USD 0.37%
2021 2.94 Billion USD -9.76%
2020 3.26 Billion USD 0.0%

Peer Operating Expenses Comparison of Sandoz Group AG

Name Operating Expenses Operating Expenses Difference
Relief Therapeutics Holding AG 114.94 Million CHF -3019.447%
Tecan Group AG 254.49 Million CHF -1308.856%
Santhera Pharmaceuticals Holding AG 31.33 Million CHF -11342.553%
Basilea Pharmaceutica AG 111.63 Million CHF -3111.828%
Bachem Holding AG 47.58 Million CHF -7435.305%
Siegfried Holding AG 148.34 Million CHF -2317.099%
Molecular Partners AG 20.3 Million CHF -17560.94%